Fulcrum Therapeutics's total assets for Q3 2024 were $260.72M, a decrease of -6.56% from the previous quarter. FULC total liabilities were $17.68M for the fiscal quarter, a -18.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.